I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Ipilimumab plus nivolumab in avelumab-refractory Merkel cel..:
Glutsch, Valerie
;
Schummer, Patrick
;
Kneitz, Hermann
...
https://mediatum.ub.tum.de/1693361. , 2022
Link:
https://mediatum.ub.tum.de/1693361
RT Journal T1
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG
UL https://suche.suub.uni-bremen.de/peid=base-fttumuenchen:oai:mediatum.ub.tum.de:node_1693361&Exemplar=1&LAN=DE A1 Glutsch, Valerie A1 Schummer, Patrick A1 Kneitz, Hermann A1 Gesierich, Anja A1 Goebeler, Matthias A1 Klein, Detlef A1 Posch, Christian A1 Gebhardt, Christoffer A1 Haferkamp, Sebastian A1 Zimmer, Lisa A1 Becker, Jürgen C A1 Leiter, Ulrike A1 Weichenthal, Michael A1 Schadendorf, Dirk A1 Ugurel, Selma A1 Schilling, Bastian PB BMJ Publishing Group Ltd YR 2022 K1 info:eu-repo/classification/ddc/ K1 Clinical/translational cancer immunotherapy K1 Skin Neoplasms K1 CTLA-4 Antigen K1 Programmed Cell Death 1 Receptor K1 B7-H1 Antigen K1 Drug Therapy K1 Combination JF https://mediatum.ub.tum.de/1693361 LK http://dx.doi.org/https://mediatum.ub.tum.de/1693361 DO https://mediatum.ub.tum.de/1693361 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)